Plozasiran Clinical Trials (2026): 8 Studies for Severe Hypertriglyceridemia & Familial Chylomicronemia

Where to Participate: All Plozasiran Trial Sites in the U.S. (92 sites across 23 states)

Every actively recruiting Plozasirantrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Plozasiran clinical trials at a glance: phase × recruitment status

Recruiting Plozasiran clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Plozasiran clinical trials by indication

Plozasiran pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Plozasiran trials (8)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Plozasiran clinical trials: frequently asked questions

How many Plozasiran clinical trials are there?

8 Plozasiran clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 2 are marked completed.

Are Plozasiran clinical trials recruiting in 2026?

Yes — 2 Plozasiran trials are actively recruiting in 2026, with 92 U.S. sites across 23 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Plozasiran being studied for?

Plozasiran is being studied for Severe Hypertriglyceridemia, Familial Chylomicronemia, Hypertriglyceridemia, Familial Chylomicronemia Syndrome, High Risk Severe Hypertriglyceridemia (SHTG). The trials are grouped by indication on this page.

What phase is Plozasiran in?

Plozasiran clinical trials span 7 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Plozasiran clinical trials?

The lead sponsor across the most Plozasiran trials is Arrowhead Pharmaceuticals, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Plozasiranas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.